Harvard Business School (HBS) has announced the 2023-2024 cohort of Blavatnik Fellows. Celebrating its tenth anniversary, the Blavatnik Fellowship in Life Science Entrepreneurship was launched in 2013 as part of a gift to Harvard University from the Blavatnik Family Foundation. The fellowship offers HBS alumni and Harvard-affiliated postdocs the opportunity to work closely with leading biotech industry and biomedical authorities, receive mentorship, and join a community of entrepreneurs shaping the future of science. To date, Blavatnik Fellows have created 35 companies in biomedical industries, including: a novel enzymatic RNA synthesis platform, an immune system-driven dendritic cell therapy to combat cancer, new molecular technologies for the delivery of transdermal formulations, a lipid-targeting drug to treat cancer and neurodegenerative disorders, and a tumor oxygen sensor for personalized oncology care.
Harvard Business School Announces Its 2023-2024 Blavatnik Fellows Harvard Business School
Providing many of the world's best researchers, scientists, and universities with support, and funding to discover breakthroughs that solve humankind's greatest challenges.
The Foundation contributes to renowned institutions that showcase the breadth of arts and culture, including performance, exhibition and education.
The Blavatnik Archive is a nonprofit foundation dedicated to preserving and disseminating materials that contribute to the study of 20th-century Jewish and world history, with a special emphasis on World War I, World War II, and Soviet Russia.